Related Articles
Downregulation of miR‑200c‑3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2
SET and MYND domain‑containing protein 3 inhibits tumor cell sensitivity to cisplatin
Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis